Evidence map›Paper›PMID 21643783›Full record

ReviewCurrent HIV/AIDS reports2011

Renal issues in HIV infection.

Robert C Kalayjian

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01869010 (Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01869010 completednot on this map

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

TypeobservationalSponsorHospital Italiano de Buenos AiresRan2010 to 2012Enrolled30ConditionsHIV InfectionArmsLow sodium water overload in HIV tenofovir, HIV no tenofovir and seronegative controls
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Impaired Urine Dilution Capability in HIV Stable Patients.International journal of nephrology · 2014
    Article
  7. Microalbuminuria in HIV disease.American journal of nephrology · 2013
    Article
  8. Renal dysfunction in the setting of HIV/AIDS.Current HIV/AIDS reports · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert C KalayjianDivision of Infectious Diseases, MetroHealth Medical Center, Cleveland, OH 44109, USA. rkalayjian@metrohealth.org

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney disease remains a prominent complication of HIV disease, despite beneficial effects of antiretroviral therapy on the natural history of HIV-associated nephropathy, and on kidney function in general populations of HIV infected patients. Persons of African descent continue to bear a disproportionate burden of severe kidney disease, as is true for the general population. Recently identified genetic variants in the apolipoprotein L1 gene may contribute to this burden. As is also true for the general population, markers of kidney disease, including microalbuminuria, are sensitive predictors of cardiovascular disease and mortality among persons living with HIV. The emerging experience with kidney transplantation also suggests this to be a viable option in selected patients.

Indexed as

Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveHIVHIV InfectionsHumansKidney DiseasesAnti-HIV Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.